By
Gerald Imray
Published: Sept. 15, 2023, 6:58 a.m.·
Tags:
Treatment,
Access
U.S.-based pharmaceuticals company Johnson & Johnson is being investigated in South Africa for allegedly charging “excessive” prices for a key tuberculosis drug, the country's antitrust regulator said Friday (15 September).
Read More →